Omeros Corporation [NASDAQ: OMER] gained 1.62% or 0.18 points to close at $11.26 with a heavy trading volume of 1564908 shares. The company report on October 16, 2020 that Omeros’ OMS906 Data Presented at Complement-based Drug Development Summit.
Omeros Corporation (Nasdaq: OMER) presented data from its OMS906 program yesterday at the 4th Complement-based Drug Development Summit. OMS906 is the company’s lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-3 (MASP-3), the key activator of the complement system’s alternative pathway. The presentation about the inhibition of the alternative pathway by targeting MASP-3 was made by Jason Cummings, Ph.D., Omeros’ Associate Director for Research. Dr. Cummings’ slide presentation can be viewed at https://investor.omeros.com/presentations.
Believed to be the premier target in the alternative pathway, MASP-3 is responsible for the conversion of pro-complement factor D to mature complement factor D (CFD), and OMS906 is designed to block that conversion. The presentation included data demonstrating that a single dose of OMS906 in an animal study demonstrated a decrease of mature CFD and an increase and accumulation in pro-CFD levels that remained detectable for more than three weeks. Data also showed that lowest levels of detectable mature CFD correlated with complete inactivation of the alternative pathway.
It opened the trading session at $11.71, the shares rose to $12.275 and dropped to $11.12, the range by which the price of stock traded the whole day. The daily chart for OMER points out that the company has recorded -21.26% loss over the past six months. However, it is still -32.47% lower than its most recent low trading price.
If we look at the average trading volume of 1.55M shares, OMER reached to a volume of 1564908 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Omeros Corporation [OMER]:
BofA Securities have made an estimate for Omeros Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 20, 2020. While these analysts kept the previous recommendation, H.C. Wainwright dropped their target price from $34 to $32. The new note on the price target was released on August 21, 2020, representing the official price target for Omeros Corporation stock. Previously, the target price had yet another drop from $25 to $20, while Maxim Group kept a Buy rating on OMER stock.
The Average True Range (ATR) for Omeros Corporation is set at 0.67, with the Price to Sales ratio for OMER stock in the period of the last 12 months amounting to 6.86.
Trading performance analysis for OMER stock
Omeros Corporation [OMER] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.81. With this latest performance, OMER shares dropped by -3.43% in over the last four-week period, additionally sinking by -21.26% over the last 6 months – not to mention a drop of -29.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OMER stock in for the last two-week period is set at 50.73, with the RSI for the last a single of trading hit 53.87, and the three-weeks RSI is set at 48.90 for Omeros Corporation [OMER]. The present Moving Average for the last 50 days of trading for this stock 11.57, while it was recorded at 11.22 for the last single week of trading, and 13.52 for the last 200 days.
Omeros Corporation [OMER]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Omeros Corporation [OMER] shares currently have an operating margin of -56.69 and a Gross Margin at +97.63. Omeros Corporation’s Net Margin is presently recorded at -75.57.
Return on Total Capital for OMER is now -93.00, given the latest momentum, and Return on Invested Capital for the company is -128.09. Additionally, OMER Total Debt to Total Capital is recorded at 228.24, with Total Debt to Total Assets ending up at 141.66.
Reflecting on the efficiency of the workforce at the company, Omeros Corporation [OMER] managed to generate an average of -$327,465 per employee. Receivables Turnover for the company is 3.86 with a Total Asset Turnover recorded at a value of 0.96.Omeros Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.00.
Omeros Corporation [OMER]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Omeros Corporation posted -0.33/share EPS, while the average EPS was predicted by analysts to be reported at -0.41/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 19.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OMER.
An analysis of insider ownership at Omeros Corporation [OMER]
There are presently around $358 million, or 52.60% of OMER stock, in the hands of institutional investors. The top three institutional holders of OMER stocks are: BLACKROCK INC. with ownership of 4,478,599, which is approximately 6.005% of the company’s market cap and around 0.10% of the total institutional ownership; INGALLS & SNYDER LLC, holding 4,437,568 shares of the stock with an approximate value of $49.97 million in OMER stocks shares; and CONSONANCE CAPITAL MANAGEMENT LP, currently with $46.95 million in OMER stock with ownership of nearly -6.92% of the company’s market capitalization.
Positions in Omeros Corporation stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 67 institutional holders increased their position in Omeros Corporation [NASDAQ:OMER] by around 1,917,902 shares. Additionally, 57 investors decreased positions by around 1,386,973 shares, while 22 investors held positions by with 28,497,513 shares. The mentioned changes placed institutional holdings at 31,802,388 shares, according to the latest SEC report filing. OMER stock had 18 new institutional investments in for a total of 303,527 shares, while 25 institutional investors sold positions of 587,727 shares during the same period.